Jilin Aodong Pharmaceutical Group Co., Ltd. (SHE:000623)
China flag China · Delayed Price · Currency is CNY
16.84
+0.45 (2.75%)
Oct 30, 2026, 3:04 PM CST

SHE:000623 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
1,3771,1631,1071,7201,4381,743
Short-Term Investments
----788704
Trading Asset Securities
1,7071,8001,5681,6581,6402,189
Cash & Short-Term Investments
3,0852,9632,6753,3783,8664,635
Cash Growth
-0.79%10.76%-20.81%-12.62%-16.59%2.71%
Accounts Receivable
930.921,0011,1571,4071,056964.31
Other Receivables
441.7225.2523.1829.9860.3168.53
Receivables
1,3731,0271,1811,4371,1161,033
Inventory
787.77802.1936.9872.35874.57591.88
Prepaid Expenses
-----0.16
Other Current Assets
55.2431.3840.4157.55124.6965.59
Total Current Assets
5,3004,8234,8335,7455,9826,326
Property, Plant & Equipment
2,2812,3562,5582,5342,3392,296
Long-Term Investments
28,06726,47324,64723,00321,89119,637
Other Intangible Assets
392.53404.52437.32435.35365.08359.61
Long-Term Deferred Tax Assets
313.03269.99326.23309.84303.12164.27
Long-Term Deferred Charges
29.3737.63111.57163.96212.25188.02
Other Long-Term Assets
64.2454.0488.3375.7789.8396.53
Total Assets
36,44734,41833,00232,26631,18229,067

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
279.14310.42425.71418.59450.97238.22
Accrued Expenses
69.51113.71106.87148.94183.15111.71
Short-Term Debt
771.57903.021,255678.31651.27355.52
Current Portion of Long-Term Debt
1,02024.07-2,315--
Current Portion of Leases
-9.2922.4817.8818.2325.41
Current Income Taxes Payable
25.553.595.928.2811.5219.31
Current Unearned Revenue
43.7231.6836.2526.2682.2518.36
Other Current Liabilities
852.68618.28611.75834.8817.97687.19
Total Current Liabilities
3,0622,0142,4644,4682,2151,456
Long-Term Debt
3001,299995.22-2,3032,211
Long-Term Leases
4.093.1816.5121.4917.5523.38
Long-Term Unearned Revenue
205.38212.98223.87247.38281.6313.86
Long-Term Deferred Tax Liabilities
0.821.3620.1730.0326.0624.21
Other Long-Term Liabilities
13.12-----
Total Liabilities
3,5853,5313,7204,7674,8444,029

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
1,1961,1961,1961,1681,1631,163
Additional Paid-In Capital
4,8684,8984,8524,0353,9473,980
Retained Earnings
26,54724,27522,46621,87120,74119,243
Treasury Stock
-420.01-420.01-300-720.07-570.07-400.03
Comprehensive Income & Other
562.1717.38814.1856.99753.71873.11
Total Common Equity
32,75230,66729,02827,21226,03424,859
Minority Interest
109.62220.23254.65288.01303.54179.26
Shareholders' Equity
32,86230,88729,28227,50026,33825,039
Total Liabilities & Equity
36,44734,41833,00232,26631,18229,067

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
2,0952,2392,2893,0322,9902,616
Net Cash (Debt)
989.21724385.96346.02875.842,020
Net Cash Growth
14.71%87.58%11.54%-60.49%-56.63%-0.57%
Net Cash Per Share
0.840.620.330.270.671.60
Filing Date Shares Outstanding
1,1721,1721,1721,1231,1271,139
Total Common Shares Outstanding
1,1721,1721,1801,1231,1271,139
Working Capital
2,2382,8092,3691,2773,7674,870
Book Value Per Share
27.9426.1624.6124.2323.1021.83
Tangible Book Value
32,36030,26228,59026,77625,66924,500
Tangible Book Value Per Share
27.6025.8124.2423.8422.7821.51
Buildings
-2,2902,2872,2022,1382,039
Machinery
-1,5341,5121,4911,4131,321
Construction In Progress
-324.63424.87349.54177.36179.32